JP2014101357A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014101357A5 JP2014101357A5 JP2013220736A JP2013220736A JP2014101357A5 JP 2014101357 A5 JP2014101357 A5 JP 2014101357A5 JP 2013220736 A JP2013220736 A JP 2013220736A JP 2013220736 A JP2013220736 A JP 2013220736A JP 2014101357 A5 JP2014101357 A5 JP 2014101357A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- pharmaceutical composition
- unsubstituted
- composition according
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- -1 Cyano, carboxy Chemical group 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 239000000883 anti-obesity agent Substances 0.000 claims 1
- 229940125710 antiobesity agent Drugs 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 125000004438 haloalkoxy group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013220736A JP5590587B2 (ja) | 2012-10-26 | 2013-10-24 | Ｎｐｙｙ５受容体拮抗作用を有する医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012236827 | 2012-10-26 | ||
| JP2012236827 | 2012-10-26 | ||
| JP2013220736A JP5590587B2 (ja) | 2012-10-26 | 2013-10-24 | Ｎｐｙｙ５受容体拮抗作用を有する医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014101357A JP2014101357A (ja) | 2014-06-05 |
| JP2014101357A5 true JP2014101357A5 (enExample) | 2014-08-07 |
| JP5590587B2 JP5590587B2 (ja) | 2014-09-17 |
Family
ID=51024205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013220736A Active JP5590587B2 (ja) | 2012-10-26 | 2013-10-24 | Ｎｐｙｙ５受容体拮抗作用を有する医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5590587B2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL301890A (en) | 2020-10-14 | 2023-06-01 | George Mason Res Foundation Inc | Ionizable lipids and methods of manufacture and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007244358B2 (en) * | 2006-04-28 | 2012-06-14 | Shionogi & Co., Ltd. | Amine derivative having NPY Y5 receptor antagonist activity |
| SA08290668B1 (ar) * | 2007-10-25 | 2012-02-12 | شيونوجي آند كو.، ليمتد | مشتقات أمين لها نشاط مضاد لمستقبل npy y5 واستخداماتها |
-
2013
- 2013-10-24 JP JP2013220736A patent/JP5590587B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015522045A5 (enExample) | ||
| JP2012144574A5 (enExample) | ||
| JP2015078230A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| JP2014221779A5 (enExample) | ||
| EP4643945A8 (en) | Neuroactive steroids and methods of use thereof | |
| JP2011105738A5 (enExample) | ||
| JP2017537066A5 (enExample) | ||
| JP2017514910A5 (enExample) | ||
| MX377916B (es) | Compuestos 4-amino-imidazoquinolina. | |
| JP2011518833A5 (enExample) | ||
| WO2015200481A8 (en) | Mnk inhibitors and methods related thereto | |
| JP2016515561A5 (enExample) | ||
| JP2015516427A5 (enExample) | ||
| CN107427516B8 (zh) | 7-苄基-4-(2-甲基苄基)-2,4,6,7,8,9-六氢咪唑并[1,2-a]吡啶并[3,4-e]嘧啶-5(1h)-酮、其类似物、及其盐、以及它们用于治疗的方法 | |
| EP4316591A3 (en) | Oxysterols and methods of use thereof | |
| JP2013532130A5 (enExample) | ||
| JP2013542261A5 (enExample) | ||
| RU2018101431A (ru) | Ингибиторы индоламин-2,3-диоксигеназы | |
| JP2016510326A5 (enExample) | ||
| JP2016540015A5 (enExample) | ||
| JP2017531686A5 (enExample) | ||
| JP2015516419A5 (enExample) | ||
| JP2016515550A5 (enExample) | ||
| JP2014148552A5 (enExample) |